Annual D&A
$437.00 K
-$71.00 K-13.98%
31 December 2023
Summary:
Black Diamond Therapeutics annual depreciation & amortization is currently $437.00 thousand, with the most recent change of -$71.00 thousand (-13.98%) on 31 December 2023. During the last 3 years, it has risen by +$385.00 thousand (+740.38%). BDTX annual D&A is now -13.98% below its all-time high of $508.00 thousand, reached on 31 December 2022.BDTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$86.00 K
$0.000.00%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly depreciation & amortization is currently $86.00 thousand, unchanged on 30 September 2024. Over the past year, it has dropped by -$29.00 thousand (-25.22%). BDTX quarterly D&A is now -33.33% below its all-time high of $129.00 thousand, reached on 30 September 2022.BDTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$344.00 K
-$29.00 K-7.77%
30 September 2024
Summary:
Black Diamond Therapeutics TTM depreciation & amortization is currently $344.00 thousand, with the most recent change of -$29.00 thousand (-7.77%) on 30 September 2024. Over the past year, it has dropped by -$133.00 thousand (-27.88%). BDTX TTM D&A is now -32.28% below its all-time high of $508.00 thousand, reached on 31 December 2022.BDTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.0% | -25.2% | -27.9% |
| 3 y3 years | +740.4% | +100.0% | +254.6% |
| 5 y5 years | +893.2% | +561.5% | +805.3% |
BDTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -14.0% | +740.4% | -33.3% | +100.0% | -32.3% | +254.6% |
| 5 y | 5 years | -14.0% | +893.2% | -33.3% | +855.6% | -32.3% | +805.3% |
| alltime | all time | -14.0% | +1720.8% | -33.3% | +855.6% | -32.3% | +2766.7% |
Black Diamond Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $86.00 K(0.0%) | $344.00 K(-7.8%) |
| June 2024 | - | $86.00 K(0.0%) | $373.00 K(-7.0%) |
| Mar 2024 | - | $86.00 K(0.0%) | $401.00 K(-8.2%) |
| Dec 2023 | $437.00 K(-14.0%) | $86.00 K(-25.2%) | $437.00 K(-8.4%) |
| Sept 2023 | - | $115.00 K(+0.9%) | $477.00 K(-2.9%) |
| June 2023 | - | $114.00 K(-6.6%) | $491.00 K(-2.8%) |
| Mar 2023 | - | $122.00 K(-3.2%) | $505.00 K(-0.6%) |
| Dec 2022 | $508.00 K(+147.8%) | $126.00 K(-2.3%) | $508.00 K(+0.6%) |
| Sept 2022 | - | $129.00 K(+0.8%) | $505.00 K(+20.5%) |
| June 2022 | - | $128.00 K(+2.4%) | $419.00 K(+34.7%) |
| Mar 2022 | - | $125.00 K(+1.6%) | $311.00 K(+51.7%) |
| Dec 2021 | $205.00 K | $123.00 K(+186.0%) | $205.00 K(+111.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $43.00 K(+115.0%) | $97.00 K(+42.6%) |
| June 2021 | - | $20.00 K(+5.3%) | $68.00 K(+11.5%) |
| Mar 2021 | - | $19.00 K(+26.7%) | $61.00 K(+17.3%) |
| Dec 2020 | $52.00 K(+10.6%) | $15.00 K(+7.1%) | $52.00 K(+13.0%) |
| Sept 2020 | - | $14.00 K(+7.7%) | $46.00 K(+2.2%) |
| June 2020 | - | $13.00 K(+30.0%) | $45.00 K(0.0%) |
| Mar 2020 | - | $10.00 K(+11.1%) | $45.00 K(-4.3%) |
| Dec 2019 | $47.00 K(+6.8%) | $9000.00(-30.8%) | $47.00 K(+23.7%) |
| Sept 2019 | - | $13.00 K(0.0%) | $38.00 K(+52.0%) |
| June 2019 | - | $13.00 K(+8.3%) | $25.00 K(+108.3%) |
| Mar 2019 | - | $12.00 K | $12.00 K |
| Dec 2018 | $44.00 K(+83.3%) | - | - |
| Dec 2017 | $24.00 K | - | - |
FAQ
- What is Black Diamond Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual D&A year-on-year change?
- What is Black Diamond Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly D&A year-on-year change?
- What is Black Diamond Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics TTM D&A year-on-year change?
What is Black Diamond Therapeutics annual depreciation & amortization?
The current annual D&A of BDTX is $437.00 K
What is the all time high annual D&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual depreciation & amortization is $508.00 K
What is Black Diamond Therapeutics annual D&A year-on-year change?
Over the past year, BDTX annual depreciation & amortization has changed by -$71.00 K (-13.98%)
What is Black Diamond Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of BDTX is $86.00 K
What is the all time high quarterly D&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly depreciation & amortization is $129.00 K
What is Black Diamond Therapeutics quarterly D&A year-on-year change?
Over the past year, BDTX quarterly depreciation & amortization has changed by -$29.00 K (-25.22%)
What is Black Diamond Therapeutics TTM depreciation & amortization?
The current TTM D&A of BDTX is $344.00 K
What is the all time high TTM D&A for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high TTM depreciation & amortization is $508.00 K
What is Black Diamond Therapeutics TTM D&A year-on-year change?
Over the past year, BDTX TTM depreciation & amortization has changed by -$133.00 K (-27.88%)